The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells - PubMed (original) (raw)
The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells
E W Thompson et al. Clin Exp Metastasis. 1993 Jan.
Abstract
We have previously isolated a series of MCF-7 human breast cancer cell variants which no longer require estrogen-supplementation for tumor growth in nude mice (Clarke et al. Proc Natl Acad Sci USA 86: 3649-3653, 1989). We now report that these hormone-independent and hormone-responsive variants (MIII, MCF7/LCC1) can invade locally from solid mammary fat pad tumors, and produce primary extensions on the surface of intraperitoneal structures including liver, pancreas, and diaphragm. Both lymphatic and hematogenous dissemination are observed, resulting in the establishing of pulmonary, bone, and renal metastases. The pattern of metastasis by MIII and MCF7/LCC1 cells closely resembles that frequently observed in breast cancer patients, and provides the first evidence of metastasis from MCF-7 cells growing in vivo without supplementary estrogen. The interexperimental incidence of metastases, and the time from cell inoculation to the appearance of metastatic disease are variable. The increased metastatic potential is not associated with an increase in either the level of laminin attachment, laminin receptor mRNA expression, or secreted type IV collagenolytic activity. We also did not detect a significant decrease in the steady-state mRNA levels of the metastasis inhibitor nm23 gene. However, when growing without estrogen in vitro, MCF7/LCC1 cells produce elevated levels of the estrogen-inducible cathepsin D enzyme.
Similar articles
- Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines.
Morris VL, Tuck AB, Wilson SM, Percy D, Chambers AF. Morris VL, et al. Clin Exp Metastasis. 1993 Jan;11(1):103-12. doi: 10.1007/BF00880071. Clin Exp Metastasis. 1993. PMID: 8422701 - nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL, Geisinger KR, Mehta RR, White WL, Shelton B, Kute TE. Russell RL, et al. Cancer. 1997 Mar 15;79(6):1158-65. doi: 10.1002/(sici)1097-0142(19970315)79:6<1158::aid-cncr14>3.0.co;2-z. Cancer. 1997. PMID: 9070493 - The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs.
Leonessa F, Boulay V, Wright A, Thompson EW, Brünner N, Clarke R. Leonessa F, et al. Acta Oncol. 1992;31(2):115-23. doi: 10.3109/02841869209088890. Acta Oncol. 1992. PMID: 1622625 Review. - Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression.
Clarke R, Skaar T, Baumann K, Leonessa F, James M, Lippman J, Thompson EW, Freter C, Brunner N. Clarke R, et al. Breast Cancer Res Treat. 1994;31(2-3):237-48. doi: 10.1007/BF00666157. Breast Cancer Res Treat. 1994. PMID: 7881102 Review.
Cited by
- Unraveling the Intricate Link: Deciphering the Role of the Golgi Apparatus in Breast Cancer Progression.
Dumitru AV, Stoica EE, Covache-Busuioc RA, Bratu BG, Cirstoiu MM. Dumitru AV, et al. Int J Mol Sci. 2023 Sep 14;24(18):14073. doi: 10.3390/ijms241814073. Int J Mol Sci. 2023. PMID: 37762375 Free PMC article. Review. - Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models.
Martínez-Pérez C, Ward C, Turnbull AK, Mullen P, Cook G, Meehan J, Jarman EJ, Thomson PI, Campbell CJ, McPhail D, Harrison DJ, Langdon SP. Martínez-Pérez C, et al. Br J Cancer. 2016 Apr 12;114(8):905-16. doi: 10.1038/bjc.2016.6. Epub 2016 Mar 31. Br J Cancer. 2016. PMID: 27031849 Free PMC article. - Cadmium, carcinogen, co-carcinogen and anti carcinogen.
Chandra R, Dass SK, Tomar P, Tiwari M. Chandra R, et al. Indian J Clin Biochem. 2001 Jul;16(2):145-52. doi: 10.1007/BF02864853. Indian J Clin Biochem. 2001. PMID: 23105310 Free PMC article. - Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.
Grohar PJ, Woldemichael GM, Griffin LB, Mendoza A, Chen QR, Yeung C, Currier DG, Davis S, Khanna C, Khan J, McMahon JB, Helman LJ. Grohar PJ, et al. J Natl Cancer Inst. 2011 Jun 22;103(12):962-78. doi: 10.1093/jnci/djr156. Epub 2011 Jun 8. J Natl Cancer Inst. 2011. PMID: 21653923 Free PMC article.
References
- Int J Cancer. 1986 Feb 15;37(2):173-7 - PubMed
- Cancer Res. 1989 Jan 15;49(2):357-60 - PubMed
- Clin Exp Metastasis. 1989 Jul-Aug;7(4):437-51 - PubMed
- Proc Natl Acad Sci U S A. 1989 May;86(10):3649-53 - PubMed
- Nature. 1983 Dec 15-21;306(5944):658-61 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials